MARKET

FSTX

FSTX

F-Star Therapeutics Inc
NASDAQ
4.210
-0.120
-2.77%
After Hours: 4.050 -0.16 -3.80% 17:47 01/27 EST
OPEN
4.160
PREV CLOSE
4.330
HIGH
4.320
LOW
3.810
VOLUME
1.11M
TURNOVER
0
52 WEEK HIGH
6.93
52 WEEK LOW
2.070
MARKET CAP
92.54M
P/E (TTM)
-2.0370
1D
5D
1M
3M
1Y
5Y
F-star's Delayed Acquisition Presents A Risky Opportunity
Seeking Alpha · 19h ago
Catalyst watch: Eyes on tech earnings, Chinese EV stocks, Peloton and Church & Dwight
Seeking Alpha · 1d ago
Why GeneDx Holdings Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket
Benzinga · 2d ago
F-Star Therapeutics Plunges as Sale Falters
TipRanks · 2d ago
invoX Pharma And F-star Therapeutics Issue Joint Statement; Parties Continue Working Together In Active Discussions With The Committee On Foreign Investment In The United States
Benzinga · 2d ago
Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga · 2d ago
KALA, THMO and KTRA among mid-day movers
Seeking Alpha · 2d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 2d ago
More
About FSTX
F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on developing immunotherapies to transform the lives of patients with cancer. The Company's FS118 is the lead product candidate, which is in Phase II trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing FS222, FS120 and SB 11285 in Phase I clinical trials in patients with advanced cancers. FS222 is focused on patients with tumors that express low levels of PD-L1 and is a tetravalent, bispecific natural antibody (mAb2) bispecific antibody that is designed to target both the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. FS120 is focused to improve checkpoint inhibitor and chemotherapy outcomes and is a mAb2 bispecific antibody that is designed to bind to and stimulate OX40 and CD137. Its product candidate SB 11285 is focused on improving checkpoint inhibition outcomes as an immunotherapeutic compound for the treatment of selected cancers.

Webull offers kinds of F-Star Therapeutics Inc stock information, including NASDAQ:FSTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FSTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FSTX stock methods without spending real money on the virtual paper trading platform.